Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
China SXT Pharmaceuticals, Inc. (SXTC) had Profit Margin of -189.77% for the most recently reported fiscal year, ending 2025-03-31.
| Income Statement Financials | |
$1.74M |
|
$-3.30M |
|
$1.37M |
|
$0.37M |
|
$4.42M |
|
$-2.68M |
|
$-0.62M |
|
$-3.30M |
|
$-3.30M |
|
$-3.30M |
|
$-3.30M |
|
$-3.30M |
|
$-3.30M |
|
$-2.68M |
|
$-2.60M |
|
1.42M |
|
1.42M |
|
$-2.32 |
|
$-2.32 |
|
| Balance Sheet Financials | |
$21.30M |
|
$0.18M |
|
$0.37M |
|
$21.66M |
|
$6.01M |
|
$0.10M |
|
$0.21M |
|
$6.22M |
|
$15.44M |
|
$15.43M |
|
$15.44M |
|
13.76M |
|
| Cash Flow Statement Financials | |
$-2.35M |
|
$0.06M |
|
$8.40M |
|
$12.08M |
|
$18.13M |
|
$6.05M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.54 |
|
-- |
|
-- |
|
0.01 |
|
0.05 |
|
21.11% |
|
-153.97% |
|
-153.97% |
|
-149.24% |
|
-189.77% |
|
|
Profit Margin |
-189.77% |
$-2.28M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
1.66 |
|
1.01 |
|
360.39 |
|
-21.40% |
|
-21.41% |
|
-15.25% |
|
-21.26% |
|
$1.12 |
|
$-1.60 |
|
$-1.65 |
|